Thomas H. Fraser
Keine laufenden Positionen mehr
Karriereverlauf von Thomas H. Fraser
Ehemalige bekannte Positionen von Thomas H. Fraser
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GENVEC INC | Direktor/Vorstandsmitglied | - | 01.01.2006 |
| Präsident | - | 01.01.2006 | |
Diacrin, Inc. (Delaware)
 Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Diacrin, Inc. develops human cell transplant therapeutic products. The company is headquartered in Wilmington, DE. | Direktor/Vorstandsmitglied | - | - |
| Präsident | - | - |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Director/Board Member | 2 |
| President | 2 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
Diacrin, Inc. (Delaware)
Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Diacrin, Inc. develops human cell transplant therapeutic products. The company is headquartered in Wilmington, DE. | Health Technology |
- Börse
- Insiders
- Thomas H. Fraser
- Erfahrung